Search
Menu
DataRay Inc. - ISO 11146-Compliant Laser Beam Profilers

Molecular imaging agent helps detect Alzheimer’s disease

Facebook X LinkedIn Email
Amyloid plaques accumulate in the brains of patients who develop Alzheimer’s disease for years before onset. Early detection of these plaques may enable early diagnosis and also may help scientists develop better prevention methods and treatments. A recent study showed that, when used with PET imaging, a molecular imaging agent can identify amyloid plaques in patients with Alzheimer’s disease. As presented at the eighth International Conference of Alzheimer’s Disease and Parkinson’s Disease in Salzburg, Austria, Dr. Christopher Rowe from Austin Hospital of Melbourne, Australia, and his...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: May 2007
    amyloid plaquesBiophotonicsFrom The ClinicImagingradiopharmaceutical

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.